BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32782824)

  • 21. Effects of phosphodiesterase type 5 inhibitors on choroid and ocular vasculature: a literature review.
    da Cruz NFS; Polizelli MU; Cezar LM; Cardoso EB; Penha F; Farah ME; Rodrigues EB; Novais EA
    Int J Retina Vitreous; 2020; 6():38. PubMed ID: 32782824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphologic features of large choroidal vessel layer: age-related macular degeneration, polypoidal choroidal vasculopathy, and central serous chorioretinopathy.
    Baek J; Lee JH; Jung BJ; Kook L; Lee WK
    Graefes Arch Clin Exp Ophthalmol; 2018 Dec; 256(12):2309-2317. PubMed ID: 30259090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathophysiology of macular diseases--morphology and function].
    Iida T
    Nippon Ganka Gakkai Zasshi; 2011 Mar; 115(3):238-74; discussion 275. PubMed ID: 21476310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphodiesterase inhibitors and the eye.
    Kerr NM; Danesh-Meyer HV
    Clin Exp Ophthalmol; 2009 Jul; 37(5):514-23. PubMed ID: 19624350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and clinical correlates of focal choroidal excavation in eyes with age-related macular degeneration, polypoidal choroidal vasculopathy and central serous chorioretinopathy.
    Lim FP; Wong CW; Loh BK; Chan CM; Yeo I; Lee SY; Mathur R; Wong D; Wong TY; Cheung CM
    Br J Ophthalmol; 2016 Jul; 100(7):918-923. PubMed ID: 26504178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular Response to Sildenafil Citrate in Aging and Age-Related Macular Degeneration.
    Yiu G; Vuong VS; Tran S; Migacz J; Cunefare D; Farsiu S; Khandelwal N; Agrawal R; Cheung CMG
    Sci Rep; 2019 Mar; 9(1):5049. PubMed ID: 30911094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of Macular Degeneration with Sildenafil: Results of a Two-Year Trial.
    Coleman DJ; Lee W; Chang S; Silverman RH; Lloyd HO; Daly S; Tsang SH
    Ophthalmologica; 2018; 240(1):45-54. PubMed ID: 29694963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular toxicity assessment of chronic sildenafil therapy for pulmonary arterial hypertension.
    Matieli L; Berezovsky A; Salomão SR; Allemann N; Martins EN; Hirai FE; Ota-Arakaki J; Morales MS; de Freitas D
    Graefes Arch Clin Exp Ophthalmol; 2016 Jun; 254(6):1167-74. PubMed ID: 27094700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central serous chorioretinopathy following oral tadalafil intake.
    Roy R; Panigrahi PK; Saurabh K; Das D; Lobo A
    Clin Exp Optom; 2014 Sep; 97(5):473-4. PubMed ID: 24612146
    [No Abstract]   [Full Text] [Related]  

  • 30. Does therapeutic dose of sildenafil citrate treatment lead to central serous chorioretinopathy in patients with erectile dysfunction?
    Damar E; Toklu Y; Tuncel A; Balci M; Aslan Y; Simsek S; Atan A
    Am J Mens Health; 2013 Sep; 7(5):439-43. PubMed ID: 23479433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central serous chorioretinopathy due to tadalafil use.
    Türkcü FM; Yüksel H; Şahin A; Murat M; Bozkurt Y; Çaça I
    Int Ophthalmol; 2013 Apr; 33(2):177-80. PubMed ID: 23065016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of choroidal perfusion and thickness following systemic sildenafil (Viagra(®) ).
    Kim DY; Silverman RH; Chan RV; Khanifar AA; Rondeau M; Lloyd H; Schlegel P; Coleman DJ
    Acta Ophthalmol; 2013 Mar; 91(2):183-8. PubMed ID: 22974308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optical coherence tomography in tadalafil-associated retinal toxicity.
    Coscas F; Coscas G; Zucchiatti I; Bandello F; Soubrane G; Souïed E
    Eur J Ophthalmol; 2012; 22(5):853-6. PubMed ID: 22328305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should central serous chorioretinopathy be added to the list of ocular side effects of phosphodiesterase 5 inhibitors?
    Aliferis K; Petropoulos IK; Farpour B; Matter MA; Safran AB
    Ophthalmologica; 2012; 227(2):85-9. PubMed ID: 22156704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central serous chorioretinopathy following oral tadalafil.
    Gordon-Bennett P; Rimmer T
    Eye (Lond); 2012 Jan; 26(1):168-9. PubMed ID: 22056864
    [No Abstract]   [Full Text] [Related]  

  • 36. Are phosphodiesterase type 5 inhibitors associated with vision-threatening adverse events? A critical analysis and review of the literature.
    Azzouni F; Abu samra K
    J Sex Med; 2011 Oct; 8(10):2894-903. PubMed ID: 21771280
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.